Fri, Nov 13, 2026 - Page 8
7377 indexed SquawkNews stories from this UTC day. Showing 841-960.
L
HIGH ROLLER TECHNOLOGIES INC: Q3 2026 RESULTS REFLECT LOWER ONLINE CASINO REVENUE DUE TO YOY IMPACT OF HAVING EXITED CERTAIN MARKETS IN 2025
HIGH ROLLER TECHNOLOGIES INC: Q3 2026 RESULTS REFLECT LOWER ONLINE CASINO REVENUE DUE TO YOY IMPACT
EARNINGS | Nov 13, 2026, 09:07 PM UTC
L
Korro Bio Grants New Employee Stock Option for 1,000 Shares
EQUITY | Nov 13, 2026, 09:07 PM UTC
L
FiEE 3Q EPS 8c >FIEE
FiEE 3Q EPS 8c >FIEE
EARNINGS | Nov 13, 2026, 09:07 PM UTC
H
Waterstone Financial (WSBF) Quarterly Net Income Falls to $6.2M
Waterstone Financial reported Q3 2026 net income of $6.2M, or $0.36 per diluted share, versus $7.9M and $0.45 a year earlier. Nine-month net income was $20.6M versus $18.7M.Material DetailsContext by AI AnalystThe result
EARNINGS | Nov 13, 2026, 09:07 PM UTC
L
Espey Mfg. & Electronics Corp. (ESP) Q1 Sales Rise 17%, New Orders Fall 75%
Fiscal Q1 2027 sales were $10.6M versus $9.1M a year earlier; net income was $2.2M versus $2.2M. Backlog was $126.7M versus approximately $141.1M, and new orders were $2.6M versus $10.5M.Material DetailsContext by AI Ana
EARNINGS | Nov 13, 2026, 09:07 PM UTC
L
TRex Bio, Inc. (TRXB) Expects Cash Through H2 2029 After Approx. $119M IPO
TRex Bio reported Q3 2026 financial results; the supplied release includes no financial statement figures. Its October IPO generated approximately $119M in net proceeds, and the company expects resources to fund operatio
EQUITY | Nov 13, 2026, 09:07 PM UTC
M
ESS Tech Ceases Operations and Files for Bankruptcy Relief
ESS Tech said it ceased operations on Nov. 13, 2026, and filed a voluntary petition for relief, according to its SEC filing.
EQUITY | Nov 13, 2026, 09:07 PM UTC
L
Indaptus Therapeutics Q3 Net Loss Narrows 65% to $1.05 Million
Indaptus Therapeutics Q3 Net Loss Narrows 65% to $1.05 Million Indaptus Therapeutics’ third-quar
EQUITY | Nov 13, 2026, 09:07 PM UTC
L
Femasys Inc. (FEMY) Raises $30M; Q3 U.S. Sales Increase Slightly
Femasys says Q3 2026 U.S. sales increased slightly despite significant funding constraints before its mid-August $30M financing. No year-over-year sales comparison was provided in the release.Material DetailsContext by A
EQUITY | Nov 13, 2026, 09:07 PM UTC
M
West Coast Community Bancorp Authorizes Up to $25 Million in Share Buybacks
West Coast Community Bancorp authorized share buybacks of up to $25 million.
EQUITY | Nov 13, 2026, 09:07 PM UTC
H
The Marketing Alliance Reports Fiscal Q2 Results; Financial Figures Not Provided
The Marketing Alliance announced financial results for its fiscal second quarter ended September 30, 2026, but the release text provides no revenue, earnings or other results figures.Material DetailsContext by AI Analyst
EARNINGS | Nov 13, 2026, 09:07 PM UTC
M
S&P: COTE D'IVOIRE 'BB/B' RATINGS AFFIRMED; OUTLOOK STABLE
S&P: COTE D'IVOIRE 'BB/B' RATINGS AFFIRMED; OUTLOOK STABLE
RATES | Nov 13, 2026, 09:07 PM UTC
H
Bessent knocks Lutnick on Megaspeed
Lutnick, who’d initially competed for Bessent’s job, agreed this week to testify before Congress following the news of former Nvidia CEO Jensen Huang’s affair with a Megaspeed executive who is suspected of being a Chines
GEOPOLITICS | Nov 13, 2026, 09:07 PM UTC
L
Vistagen (VTGN) Reports $10.7M Quarterly Net Loss; Cash Expected Into 2027
For the quarter ended September 30, 2026, Vistagen reported a $10.7M net loss versus $19.4M a year earlier. Cash, cash equivalents and marketable securities were $20.0M; the company expects funding into 2027, but not for
EQUITY | Nov 13, 2026, 09:07 PM UTC
L
Indaptus Therapeutics, Inc. (INDP) Q3 Net Loss Falls to $1.0M From $3.0M
Indaptus reported Q3 2026 net loss of approximately $1.0M, versus $3.0M in Q3 2025. Cash, cash equivalents and short-term investments were approximately $30.6M at September 30, 2026; $20.5M in private-placement proceeds
EQUITY | Nov 13, 2026, 09:07 PM UTC
L
Waterstone Financial, Inc. Announces Results of Operations for the Quarter and Nine Months Ended September 30, 2026
WAUWATOSA, Wis., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Waterstone Financial, Inc. NASDAQ:WSBF, holding company for WaterStone Bank, reported net income of $6.2 million, or $0.36 per diluted share, for the quarter ended Septe
EQUITY | Nov 13, 2026, 09:07 PM UTC
L
Espey Mfg. & Electronics Corp. reports first quarter results
SARATOGA SPRINGS, N.Y., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Espey Mfg. & Electronics Corp. (NYSE American: ESP) announces results for the first three months of fiscal year 2027.Net sales for the three months ended Septembe
EQUITY | Nov 13, 2026, 09:07 PM UTC
L
TRexBio Reports Third Quarter 2026 Financial Results and Recent Business Highlights
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- TRex Bio, Inc. ("TRexBio") NASDAQ:TRXB, a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregu
EQUITY | Nov 13, 2026, 09:07 PM UTC
L
Femasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Update
$30 million private placement supports commercial team build-out to drive U.S. sales growth; Q3 U.S. sales increased slightly despite significant funding constraints prior to mid-August financingATLANTA, Nov. 13, 2026 (G
EQUITY | Nov 13, 2026, 09:06 PM UTC
L
Aptera Motors Reports Third Quarter and First Nine Months 2026 Financial Results
CARLSBAD, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. NASDAQ:SEV ("Aptera" or the "Company"), a solar mobility company advancing ultra-efficient transportation, today reported its financial results for
EQUITY | Nov 13, 2026, 09:06 PM UTC
H
*-- Earnings Flash (INBX) Inhibrx Biosciences, Inc. Reports Q3 Revenue $2.0M
*-- Earnings Flash (INBX) Inhibrx Biosciences, Inc. Reports Q3 Revenue $2.0M
EARNINGS | Nov 13, 2026, 09:06 PM UTC
L
Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
NEW YORK, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. NASDAQ:INDP (“Indaptus” or the “Company”), a biotechnology company dedicated to immunotherapy research, today announced financial results for the th
EQUITY | Nov 13, 2026, 09:06 PM UTC
L
Vistagen Reports Fiscal Year 2027 Second Quarter Financial Results and Provides Corporate Update
Advancing potential to execute Phase 3 development plan for fasedienol in social anxiety disorder following constructive FDA feedback, with disciplined capital management and strategic flexibilitySOUTH SAN FRANCISCO, Cal
REGULATION | Nov 13, 2026, 09:06 PM UTC
L
The Marketing Alliance Announces Financial Results for Second Quarter Ended September 30, 2026
ST. LOUIS, Nov. 13, 2026 (GLOBE NEWSWIRE) -- The Marketing Alliance, Inc. OTC:MAAL (“TMA” or the “Company”), announced its financial results today for its fiscal 2027 second quarter ended September 30, 2026.Q2 2027 Finan
EQUITY | Nov 13, 2026, 09:06 PM UTC
L
Aptera Motors Q3 2026 net loss more than doubles to $13.97 million
Aptera Motors Q3 2026 net loss more than doubles to $13.97 million Aptera Motors’ third-quarter
EQUITY | Nov 13, 2026, 09:06 PM UTC
L
Broadway Financial Q3 2026 net income attributable to common stockholders swings to $392,000 profit year over year
Broadway Financial Q3 2026 net income attributable to common stockholders swings to $392,000 profit
EARNINGS | Nov 13, 2026, 09:06 PM UTC
L
HSBC USA Inc. Files Form FWP
HSBC USA Inc. filed a Form FWP on November 13.
EQUITY | Nov 13, 2026, 09:06 PM UTC
L
IDB Board Approves Venezuela Engagement Note
The IDB board approved an engagement note for Venezuela.
REGULATION | Nov 13, 2026, 09:06 PM UTC
L
Espey FY27 Q1 net income rises to $2.19 million; net sales climb 17% to $10.61 million
Espey FY27 Q1 net income rises to $2.19 million; net sales climb 17% to $10.61 million Espey Man
EQUITY | Nov 13, 2026, 09:06 PM UTC
L
TherapeuticsMD Q3 2026 net income from continuing operations rises to $501,000
TherapeuticsMD Q3 2026 net income from continuing operations rises to $501,000 TherapeuticsMD's
EQUITY | Nov 13, 2026, 09:06 PM UTC
L
BRIEF-Broadway Financial Corporation Q3 Net Income USD 392 Thousand
Nov 13 (Reuters) - Broadway Financial Corporation Q3 net interest margin 2.64%.
FX | Nov 13, 2026, 09:06 PM UTC
L
BRIEF-Broadway Financial Corporation Q3 Net Income USD 392 Thousand
BRIEF-Broadway Financial Corporation Q3 Net Income USD 392 Thousand Nov 13 (Reuters) - Broadway Fina
FX | Nov 13, 2026, 09:06 PM UTC
L
TRex Bio 3Q Loss $13.2M >TRXB
TRex Bio 3Q Loss $13.2M >TRXB
EQUITY | Nov 13, 2026, 09:06 PM UTC
L
Badger Meter Authorizes Up to $250 Million in Additional Buybacks
Badger Meter also declared a regular quarterly cash dividend of $0.44 per share, payable December 11, 2026, to holders of record November 30. The company is not obligated to execute the authorized repurchases.
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
TherapeuticsMD (TXMD) Reports Third-Quarter 2026 Results
TherapeuticsMD reported financial results for the three months ended September 30, 2026. The supplied release text contains no figures for the listed financial results.Material DetailsContext by AI AnalystThis is a quart
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
US Equity Indexes Mixed; Nvidia Shares Fall
US equity indexes were mixed, while Nvidia shares fell. The alert provides no move magnitudes.
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update NEW
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
The Marketing Alliance Announces Financial Results for Second Quarter Ended September 30, 2026
ST. LOUIS, Nov.
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
High Roller Technologies Reports Third Quarter 2026 Results and Highlights Commercial Launch of ROLR™ Prediction Markets Platform
ROLR™ prediction markets platform launched to the public on October 21 and began generating revenue
EARNINGS | Nov 13, 2026, 09:05 PM UTC
L
Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
NEW YORK, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc.
EQUITY | Nov 13, 2026, 09:05 PM UTC
H
Broadway Financial Corporation (BYFC) Reports Q3 Net Income of $392K
Q3 2026 net income attributable to common stockholders was $392K, versus $218K in Q2 2026 and a $24.6M loss in Q3 2025. Diluted EPS was $0.04, versus $0.02 and a $2.86 loss, respectively.Material DetailsContext by AI Ana
EARNINGS | Nov 13, 2026, 09:05 PM UTC
L
TherapeuticsMD Announces Third Quarter 2026 Financial Results
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended September 30, 2026.Third Quarter
EQUITY | Nov 13, 2026, 09:05 PM UTC
H
Broadway Financial Corporation Reports Third Quarter 2026 Results Highlighted by Improved Earnings, Strong Deposit Growth and Stable Credit
LOS ANGELES--(BUSINESS WIRE)-- Broadway Financial Corporation (“Broadway”, “we”, or the “Company”) (
EARNINGS | Nov 13, 2026, 09:05 PM UTC
L
Santander Brasil Announces Extraordinary Shareholder Meeting
Banco Santander Brasil said it will hold an extraordinary shareholder meeting.
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Enveric Biosciences (ENVB) Reports $2.5M Q3 Net Loss, $5.6M Cash
Enveric reported a Q3 2026 net loss attributable to stockholders of $2.5M versus $3.4M a year earlier; loss per share was $0.57 versus $10.81. Cash was $5.6M at September 30, 2026.Material DetailsContext by AI AnalystThi
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Vistagen Reports Fiscal Year 2027 Second Quarter Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Vistagen (Nasdaq: VTGN), a late clini
EQUITY | Nov 13, 2026, 09:05 PM UTC
H
BROADWAY FINANCIAL CORPORATION REPORTS THIRD QUARTER 2026 RESULTS HIGHLIGHTED BY IMPROVED EARNINGS, STRONG DEPOSIT GROWTH AND STABLE CREDIT
BROADWAY FINANCIAL CORPORATION REPORTS THIRD QUARTER 2026 RESULTS HIGHLIGHTED BY IMPROVED EARNINGS,
EARNINGS | Nov 13, 2026, 09:05 PM UTC
L
VISTAGEN REPORTS FISCAL YEAR 2027 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
VISTAGEN REPORTS FISCAL YEAR 2027 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
FiEE, Inc. Announces Third Quarter 2026 Unaudited Financial Results
Revenue for the First Nine Months of 2026 Surged 382.1% Year-on-Year to Approximately $9.6 MillionProfit Turnaround for the First Nine Months of 2026 with Net Income of $3.6 MillionOSAKA, Japan, Nov. 13, 2026 // -- FiEE,
EARNINGS | Nov 13, 2026, 09:05 PM UTC
L
HIGH ROLLER TECHNOLOGIES REPORTS THIRD QUARTER 2026 RESULTS AND HIGHLIGHTS COMMERCIAL LAUNCH OF ROLR™ PREDICTION MARKETS PLATFORM
HIGH ROLLER TECHNOLOGIES REPORTS THIRD QUARTER 2026 RESULTS AND HIGHLIGHTS COMMERCIAL LAUNCH OF ROLR
EQUITY | Nov 13, 2026, 09:05 PM UTC
H
Broadway Financial Corporation Reports Third Quarter 2026 Results Highlighted by Improved Earnings, Strong Deposit Growth and Stable Credit
Broadway Financial Corporation (“Broadway”, “we”, or the “Company”) (NASDAQ:BYFC), parent company of City First Bank, National Association (the “Bank”, and collectively, with the Company, “City First Broadway”), reported
EARNINGS | Nov 13, 2026, 09:05 PM UTC
L
High Roller Technologies Reports Third Quarter 2026 Results and Highlights Commercial Launch of ROLR™ Prediction Markets Platform
High Roller Technologies Reports Third Quarter 2026 Results and Highlights Commercial Launch of ROLR
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
ENVERIC BIOSCIENCES REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2026 AND PROVIDES CORPORATE UPDATE
ENVERIC BIOSCIENCES REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2026 AND PROVIDES CORPORATE UPDATE
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
THERAPEUTICSMD ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS
THERAPEUTICSMD ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
THE MARKETING ALLIANCE ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER ENDED SEPTEMBER 30, 2026
THE MARKETING ALLIANCE ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER ENDED SEPTEMBER 30, 2026
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
The Marketing Alliance Announces Financial Results for Second Quarter Ended September 30, 2026
The Marketing Alliance Announces Financial Results for Second Quarter Ended September 30, 2026 ST. L
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
FEMASYS ANNOUNCES FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2026 AND PROVIDES CORPORATE UPDATE
FEMASYS ANNOUNCES FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2026 AND PROVIDES CORPORATE UPDA
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
APTERA MOTORS REPORTS THIRD QUARTER AND FIRST NINE MONTHS 2026 FINANCIAL RESULTS
APTERA MOTORS REPORTS THIRD QUARTER AND FIRST NINE MONTHS 2026 FINANCIAL RESULTS
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
FIEE, INC. ANNOUNCES THIRD QUARTER 2026 UNAUDITED FINANCIAL RESULTS
FIEE, INC. ANNOUNCES THIRD QUARTER 2026 UNAUDITED FINANCIAL RESULTS
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
ESPEY MFG. & ELECTRONICS CORP. REPORTS FIRST QUARTER RESULTS
ESPEY MFG. & ELECTRONICS CORP.
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
INDAPTUS THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
INDAPTUS THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Enveric Biosciences Reports Financial Results for Third Quarter 2026 and Provides Corporate Update
Enveric Biosciences (NASDAQ:ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today reported finan
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Vistagen Therapeutics 2Q Loss/Shr 24c >VTGN
Vistagen Therapeutics 2Q Loss/Shr 24c >VTGN
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
BROADWAY FINANCIAL CORPORATION Q3 NET INTEREST MARGIN 2.64%
BROADWAY FINANCIAL CORPORATION Q3 NET INTEREST MARGIN 2.64%
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Aptera Motors 3Q Loss/Shr 35c >SEV
Aptera Motors 3Q Loss/Shr 35c >SEV
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
ENVERIC BIOSCIENCES Q3 NET INCOME USD -2.5 MILLION
ENVERIC BIOSCIENCES Q3 NET INCOME USD -2.5 MILLION
FX | Nov 13, 2026, 09:05 PM UTC
L
Femasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Update
Femasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Upda
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Espey Mfg. & Electronics Corp. reports first quarter results
SARATOGA SPRINGS, N.Y., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Espey Mfg.
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
THERAPEUTICSMD Q3 NET INCOME FROM CONT OPS USD 501 THOUSAND
THERAPEUTICSMD Q3 NET INCOME FROM CONT OPS USD 501 THOUSAND
FX | Nov 13, 2026, 09:05 PM UTC
L
BROADWAY FINANCIAL CORPORATION Q3 NET INCOME USD 392 THOUSAND
BROADWAY FINANCIAL CORPORATION Q3 NET INCOME USD 392 THOUSAND
FX | Nov 13, 2026, 09:05 PM UTC
L
FiEE, Inc. Announces Third Quarter 2026 Unaudited Financial Results
Revenue for the First Nine Months of 2026 Surged 382.1% Year-on-Year to Approximately $9.6 Million P
EARNINGS | Nov 13, 2026, 09:05 PM UTC
L
Femasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Update
ATLANTA, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Femasys Inc.
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
TherapeuticsMD Announces Third Quarter 2026 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Enveric Biosciences Reports Financial Results for Third Quarter 2026 and Provides Corporate Update
EB-003 Development Highlights: Advancing final IND-enabling activities to support the planned EB-003
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Aptera Motors Reports Third Quarter and First Nine Months 2026 Financial Results
Reports Q3 2026 GAAP Net Loss of $14.0 Million and First Nine Months 2026 GAAP Net Loss of $35.0 Mil
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Vistagen Reports Fiscal Year 2027 Second Quarter Financial Results and Provides Corporate Update
Vistagen Reports Fiscal Year 2027 Second Quarter Financial Results and Provides Corporate Update S
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Aptera Motors Reports Third Quarter and First Nine Months 2026 Financial Results
Aptera Motors Reports Third Quarter and First Nine Months 2026 Financial Results Reports Q3 2026 GAA
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
Broadway Financial 3Q EPS 4c >BYFC
Broadway Financial 3Q EPS 4c >BYFC
EARNINGS | Nov 13, 2026, 09:05 PM UTC
L
Espey Mfg. & Electronics Corp. reports first quarter results
Espey Mfg. & Electronics Corp.
EQUITY | Nov 13, 2026, 09:05 PM UTC
M
Microsoft Says Outlook, Teams Outage Eases After More Than a Day
Microsoft’s Outlook and Teams outage is easing after more than a day, but the recovery timeline remains uncertain.
EQUITY | Nov 13, 2026, 09:05 PM UTC
L
HSBC USA Inc. Files Form FWP
HSBC USA Inc. filed a Form FWP on November 13; the filing date is incomplete in the supplied text.
EQUITY | Nov 13, 2026, 09:05 PM UTC
H
Fed: AI Computing Investment Has Been Accelerating
Suggests Pace Of Current Cycle s Investment May Soon Surpass 1990s Telecom Cycle - 87% Of Survey Respondents Cited AI As A Salient Risk To Financial Stability - AI Is Most-Cited Risk To The Financial System In Latest Rep
CENTRAL_BANK | Nov 13, 2026, 09:04 PM UTC
L
Bunge Files Initial Beneficial Ownership Statement for Legal Officer
Bunge filed an initial beneficial ownership statement for Chief Legal Officer Ignacio J Walker.
EQUITY | Nov 13, 2026, 09:04 PM UTC
L
Waterstone 3Q Noninterest Income $19.3M >WSBF
Waterstone 3Q Noninterest Income $19.3M >WSBF
EQUITY | Nov 13, 2026, 09:04 PM UTC
L
INHIBRX BIOSCIENCES - EXPECTS INITIAL PHASE 1/2 ORDASTOBART RESULTS IN NSCLC IN MID-2027
INHIBRX BIOSCIENCES - EXPECTS INITIAL PHASE 1/2 ORDASTOBART RESULTS IN NSCLC IN MID-2027
EQUITY | Nov 13, 2026, 09:04 PM UTC
L
Waterstone 3Q Net Interest Income $16.4M >WSBF
Waterstone 3Q Net Interest Income $16.4M >WSBF
EQUITY | Nov 13, 2026, 09:04 PM UTC
L
Elon Musk: A Petition Is Underway To Reinstate Jensen Huang And I’m Signing It Too - x
READ HERE
NEWS | Nov 13, 2026, 09:04 PM UTC
L
Waterstone Financial Reports $6.2 Million Quarterly Net Income
Waterstone Financial reported net income of $6.2 million, or $0.36 per diluted share, for the quarter ended September 30, 2026, compared with $7.9 million, or $0.45 per diluted share, a year earlier. For the first nine m
EQUITY | Nov 13, 2026, 09:03 PM UTC
L
Moderna CLO Shannon Klinger to Retire in 2027
A filing says Shannon Klinger will remain employed through March 31, 2027, under an agreement that includes severance and other potential payments.
EQUITY | Nov 13, 2026, 09:03 PM UTC
L
Moderna Chief Legal Officer Shannon Thyme Klinger to Retire March 31, 2027
EQUITY | Nov 13, 2026, 09:03 PM UTC
L
Nvidia's weekly decline erases more than $573 billion in value $NVDA
Nvidia's weekly decline erases more than $573 billion in value $NVDA
NEWS | Nov 13, 2026, 09:03 PM UTC
L
TRexBio Q3 Net Loss Widens 68% to $13.24 Million
TRexBio Q3 Net Loss Widens 68% to $13.24 Million TRexBio’s third-quarter 2026 net loss widened 6
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
Inhibrx Biosciences, Inc. (INBX) Reports Q3 2026 Results
Inhibrx Biosciences reported third-quarter 2026 financial results. The provided release contains no financial figures or comparisons.Material DetailsContext by AI AnalystThis is a routine quarterly disclosure from a clin
EQUITY | Nov 13, 2026, 09:02 PM UTC
M
Inhibrx Biosciences Q3 Net Loss Widens 10% to $38.73 Million
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
Inhibrx Reports Third Quarter 2026 Financial Results
SAN DIEGO, Nov. 13, 2026 // -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) (Inhibrx or the Company) today reported financial results for the third quarter of 2026. The biopharmaceutical company has two programs in ongoing c
EQUITY | Nov 13, 2026, 09:02 PM UTC
H
Fiscal debt sustainability rises two spots to fifth on list of financial system risks: Fed report
Fiscal debt sustainability rises two spots to fifth on list of financial system risks: Fed report
CENTRAL_BANK | Nov 13, 2026, 09:02 PM UTC
L
Gold X2 Mining Inc. (AUXX) Files Q3 2026 Statements; Results Not Disclosed
Gold X2 Mining Inc. filed its third-quarter 2026 financial statements and related MD&A with Canadian securities regulators; the release provides no financial results.Material DetailsContext by AI AnalystThis is a routine
COMMODITIES | Nov 13, 2026, 09:02 PM UTC
L
Jana Built New Stake in Modine Before Takeover-Talk Rally
Jana built a new stake in Modine before the stock surged on takeover talk.
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
US Treasury: Govt Is $694.1Bln Away From $41.1 Tln Borrowing Limit As Of 12th November
US Treasury: Govt Is $694.1Bln Away From $41.1 Tln Borrowing Limit As Of 12th November
NEWS | Nov 13, 2026, 09:02 PM UTC
H
Several respondents noted concerns that persistent deficits and heavy treasury issuance could trigger a disorderly rise in yields - Fed report
Several respondents noted concerns that persistent deficits and heavy treasury issuance could trigger a disorderly rise in yields - Fed report
CENTRAL_BANK | Nov 13, 2026, 09:02 PM UTC
L
BRIEF-Waterstone Financial Q3 Net Interest Income USD 16.416 Million
Nov 13 (Reuters) - Waterstone Financial Q3 credit loss provision USD 443 thousand.
FX | Nov 13, 2026, 09:02 PM UTC
L
Waterstone Financial September-quarter net income falls 22% year over year to $6.17 million
Waterstone Financial September-quarter net income falls 22% year over year to $6.17 million Wate
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
Inhibrx Reports Third Quarter 2026 Financial Results
SAN DIEGO, Nov. 13, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc.
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
Inhibrx Biosciences 3Q Rev $2M >INBX
Inhibrx Biosciences 3Q Rev $2M >INBX
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
TRexBio Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Positive Phase 1a results for TRB-061 support proof of mechanism, with topline Phase 1b data in atop
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
Inhibrx Biosciences 3Q Loss/Shr $2.46 >INBX
Inhibrx Biosciences 3Q Loss/Shr $2.46 >INBX
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
Inhibrx Biosciences 3Q Loss $38.7M >INBX
Inhibrx Biosciences 3Q Loss $38.7M >INBX
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
BRIEF-Waterstone Financial Q3 Net Interest Income USD 16.416 Million
BRIEF-Waterstone Financial Q3 Net Interest Income USD 16.416 Million Nov 13 (Reuters) - Waterstone F
FX | Nov 13, 2026, 09:02 PM UTC
L
INHIBRX Q3 OPERATING INCOME USD -31.735 MILLION
INHIBRX Q3 OPERATING INCOME USD -31.735 MILLION
FX | Nov 13, 2026, 09:02 PM UTC
L
INHIBRX Q3 LICENSE FEE REVENUE USD 2 MILLION
INHIBRX Q3 LICENSE FEE REVENUE USD 2 MILLION
EARNINGS | Nov 13, 2026, 09:02 PM UTC
L
INHIBRX Q3 NET INCOME USD -38.733 MILLION
INHIBRX Q3 NET INCOME USD -38.733 MILLION
FX | Nov 13, 2026, 09:02 PM UTC
L
INHIBRX Q3 EPS USD -2.46
INHIBRX Q3 EPS USD -2.46
EARNINGS | Nov 13, 2026, 09:02 PM UTC
L
INHIBRX REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
INHIBRX REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
TRexBio Reports Third Quarter 2026 Financial Results and Recent Business Highlights
TRexBio Reports Third Quarter 2026 Financial Results and Recent Business Highlights Positive Phase 1
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
TREXBIO REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
TREXBIO REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
EQUITY | Nov 13, 2026, 09:02 PM UTC
L
SuperQ Quantum Computing Appoints Julien Bui CFO
SuperQ says Patrick Hone is stepping down as CFO and will facilitate a structured handover.
EQUITY | Nov 13, 2026, 09:01 PM UTC
L
US Regulators Advance Crypto Trust Charters Amid Senate Scrutiny
Federal regulators are opening avenues for crypto companies to operate under US rules as congressional investigators seek records related to trust charters and compliance.
REGULATION | Nov 13, 2026, 09:01 PM UTC
H
vulnerabilities tied to financial leverage remain 'notable '; hedge fund leverage at highest level since 2013 - Fed Report
vulnerabilities tied to financial leverage remain 'notable '; hedge fund leverage at highest level since 2013 - Fed Report
CENTRAL_BANK | Nov 13, 2026, 09:01 PM UTC
L
American Fusion Inc. (OTCQB: AMFN) Reports Third Quarter 2026 Results and $1.55 Million in Year-To-Date Financing
Stockholders’ deficit narrowed 34% from June 30. The Company converted $987,000 of accrued compensation to equity and appointed Brent Nelson as Chief Executive OfficerSOUTHLAKE, Texas, Nov. 13, 2026 (GLOBE NEWSWIRE) -- A
ENERGY | Nov 13, 2026, 09:01 PM UTC
H
Advanced-computing-related debt issuance rose to over $680 bln by October 2026, a fivefold increase from 2023 levels - Fed Report
Advanced-computing-related debt issuance rose to over $680 bln by October 2026, a fivefold increase from 2023 levels - Fed Report
CENTRAL_BANK | Nov 13, 2026, 09:01 PM UTC